Evidence map›Paper›PMID 29627848›Full record

ArticleInternational orthopaedics2018

Fixation augmentation using calcium-phosphate bone substitute improves outcomes of complex tibial plateau fractures. A matched, cohort study.

Matthieu Ollivier, Yassine Bulaïd, Christophe Jacquet, Sebastien Pesenti, Jean-Noel Argenson, Sebastien Parratte

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in International orthopaedics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Treatment of tibial plateau fractures with a novel fenestrated screw system for delivery of bone graft substitute.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2021
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Matthieu OllivierInvestigation performed at St. Marguerite Hospital, Aix-Marseille University, Marseille, France. ollivier.matthieu@yahoo.fr.
Yassine BulaïdInvestigation performed at St. Marguerite Hospital, Aix-Marseille University, Marseille, France.
Christophe JacquetInvestigation performed at St. Marguerite Hospital, Aix-Marseille University, Marseille, France.
Sebastien PesentiInvestigation performed at St. Marguerite Hospital, Aix-Marseille University, Marseille, France.
Jean-Noel ArgensonInvestigation performed at St. Marguerite Hospital, Aix-Marseille University, Marseille, France.
Sebastien ParratteInvestigation performed at St. Marguerite Hospital, Aix-Marseille University, Marseille, France.
Institut des Sciences du Mouvement Etienne-Jules Marey · FRAix-Marseille Université · FRHôpital Sainte-Marguerite · FRInstitut des Sciences Moléculaires · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInjectable cements have been developed to improve fixation's stability and thus obtain early return to adequate joint function. We aimed to compare post-operative radiographic and clinical outcomes of patients suffering from a complex tibial plateau fracture (TPF) fixed with calcium-phosphate bone substitutes (CPBS) augmentation to a matched group of patients with identical fracture pattern, treated with the same fixation's type, but augmented with bone grafting.

methodsAfter local ethic committee approval, we retrospectively identified in a prospectively collected database, patients with complex comminuted metaphyseal and epiphysial bicondylar TPF (Schatzker type VI) admitted in our emergency department between January 2011 and December 2013. From those, 23 patients (14 males, 9 females) were treated with CPBS (Quickset-CP®, Graftys, Aix-en-Provence, France) fixation augmentation. Patients' mean age were 44.4 years. We then created a control group using a 1:1 matching process on gender, age, fracture pattern, and method of fixation. Patients were evaluated prospectively at 3, 6, and then every six  months using radiographic (AP/ML views) and clinical criteria (knee osteoarthritis outcomes score (KOOS) and EuroQOL-5D).

resultsArticular step-off and variation of articular step-off were significantly lower in the CPBS groups (mean step-off 1.4 ± 1.9 (0.5-6.5 mm) and mean step-off Δ = 0.3 ± 0.4 (0.5-2.2 mm)) than in the control group (mean step-off 3.6 ± 2.1 (1-7.5 mm) and mean step-off Δ = 2.2 ± 2 (0.5-7 mm) p < 0.01). At last follow-up, patients of the control group presented a higher rate of step-off > 2 mm and step-off Δ > 2 mm (respectively, 56 and 35%) than patients of the CPBS group (26 and 9%). Odd ratio of, respectively, 3.6 (95% CI (1.08-12.7) and p = 0.03) and 5.6 (95% CI (1.04-30.1) and p = 0.03).At mean follow-up of 29 months, KOOS pain subscore was significantly better in patients of the CPBS group (85.3 ± 12.1) than in control patients (74.2 ± 10.4 and p = 0.03).

conclusionThe present study demonstrates that calcium-phosphate bone substitute used as synthesis augmentation improves mid-term radiological outcomes of patients suffering from complex tibial plateau fracture. Series reporting outcomes from a larger number of patients and longer follow-up must confirm clinical benefits and safety of this method.

Indexed as

AdolescentAdultAgedAged, 80 and overBone SubstitutesBone TransplantationCalcium PhosphatesFemaleFollow-Up StudiesFractures, ComminutedHumansMaleMiddle AgedPostoperative PeriodRetrospective StudiesTibial FracturesBone Substitutescalcium phosphateCalcium PhosphatesAugmentationClinical outcomesCT-ScanOsteosynthesisPhosphocalcic cementTibial Plateau Fractures

Identifiers

PMID29627848
OpenAlexW2795531178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.